<DOC>
	<DOCNO>NCT01680874</DOCNO>
	<brief_summary>The purpose study determine whether probiotic , use together standard treatment , effective reduce duration symptom prevent recurrence infection old adult first episode C. difficile infection .</brief_summary>
	<brief_title>Probiotics Clostridium Difficile Infection Older Adults</brief_title>
	<detailed_description>Probiotics live microorganism available counter , widely use dietary supplement nutritional food , represent low-cost , well tolerate , safe , non-antibiotic base strategy may efficacy adjunctive treatment infection without attendant risk promote antimicrobial resistance . Certain probiotic demonstrated inhibition adherence pathogenic bacteria stimulation systemic immune function , possibly enhance body 's ability eradicate C. difficile gastrointestinal tract . However , limited data available efficacy probiotic ameliorate C. difficile symptom reduce recurrence C. difficile infection ( CDI ) . The investigator propose pilot randomize , double-blind , placebo-controlled clinical trial old adult inpatient first episode CDI evaluate efficacy probiotic combination , conjunction standard treatment , reduce duration diarrhea recurrence CDI .</detailed_description>
	<criteria>Adult either gender , 18 year old first episode C. difficile infection Meets case definition C. difficile infectionâ€”diarrhea associate positive stool test C. difficile toxin ( ) 2 day prior enrollment treated metronidazole vancomycin Severe disease define follow : WBC &gt; 30,000 &lt; 1000 cells/mm^3 , elevate creatinine &gt; 1.5 time premorbid level , ICU patient time C. difficile infection diagnose Has know etiology diarrhea ( e.g . enteric pathogen , intestinal disease ) Has history chronic intestinal disease ( e.g . Crohn 's disease , ulcerative colitis ) Has presence toxic megacolon ileus Has presence colostomy nasogastric tube Has history abdominal surgery within previous 3 month ( time enrollment ) Is enrol another investigational drug trial Is unavailable followup visit History multiple C. difficile infection Willing take probiotic duration study Is severely immunocompromised .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Clostridium difficile</keyword>
	<keyword>Diarrhea</keyword>
	<keyword>Infection</keyword>
	<keyword>Lactobacilli</keyword>
	<keyword>Bifidobacteria</keyword>
	<keyword>Lactobacillus acidophilus</keyword>
	<keyword>Lactobacillus paracasei</keyword>
	<keyword>Bifidobacterium lactis</keyword>
	<keyword>Yogurt</keyword>
	<keyword>Probiotics</keyword>
</DOC>